Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022

CAMBRIDGE, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK ), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that management will be attending the William Blair Biotech Focus Conference 2022 in New York City. Codiak's Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a panel discussion entitled "Developing Therapies for the Next Immuno-Oncology Targets," on Tuesday, July 12 from 4:10 - 5:20 pm ET and the Company will also be hosting one-on-one meetings at the conference. About Codiak BioSciences Codiak is a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with ... Full story available on Benzinga.com